Amgen, Roche Battle Heads To Trial
A federal court judge has ruled that Roche Holding AG's anemia drug Mircera violates one Amgen Inc. patent, but will let the dispute over two additional patents go to trial after...To view the full article, register now.
Already a subscriber? Click here to view full article